The Association for Pathology Informatics gratefully acknowledges the financial support given by Corporate Sponsors.
Abbott Informatics provides leading Laboratory Information Management Systems (LIMS) solutions that have served customers around the world for more than 30 years. The Abbott Informatics’ STAR LIMS solutions improve the reliability of laboratory sampling processes, support compliance with global regulatory requirements and industry standards, and provide comprehensive reporting, monitoring and analysis capabilities. With 12 development and support centers throughout the world, Abbott Informatics solutions are used in labs across multiple industries and disciplines including clinical, pharmaceutical, forensic, food safety, manufacturing, petrochemical, public health, and life sciences.
Gestalt Diagnostics is a private, profit-driven software company who has developed PathFlow, an enterprise software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories. This product was originally developed, by what is now Gestalt’s team, to support a fully digital reading platform for radiology. The radiology platform is used in leading hospitals across the United States and supports more than 15 million studies annually. Gestalt has expanded and redesigned this proven, robust solution to work in the laboratory space – engineered for the unique needs and workflow of pathologists.
Hamamatsu Photonics products and technology include optical sensors, light sources, and systems that use these components. They are applied to various new technologies and devices to support people’s lives and to help achieve a more comfortable and prosperous society. For example, our products are widely used for state-of-the-art medical equipment, test and inspection systems, microscopes that reveal the functions of cells, and giant telescopes that explore the mysteries of the universe.
Ibex is the pioneer in applying computational pathology to cancer diagnostics. Based out of Tel Aviv, Israel, the company's machine learning experts, data scientists and pathologists use artificial intelligence (AI) to develop clinical grade algorithms that can detect prostate cancer as accurately as a human pathologist.
Pathologists are challenged to provide accurate and timely analysis as the number of tests increases year-over-year. In an effort to improve their workflow, pathology labs are starting to adopt digital technologies, including AI-based analysis of biopsies. Ibex's algorithms analyzes biopsy images, detects cancerous cells, grades them and can also detect other clinically significant features. The analysis is presented to pathologists either before or after reviewing the case, helping them in reducing error rates and improving operational efficiency by reducing the average time spent on a case.
Deployed in Israel, Europe and the United States, Ibex's solution is the first-ever AI-based cancer diagnosis solution in routine clinical use in a pathology lab and has already demonstrated success in detecting missed cancer cases. The first application Ibex released is for prostate and breast and it works on expanding to additional tissues. Ibex recently raised $15 million from prominent VC funds and corporate investors.
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make faster, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy. Our products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first and only company to receive FDA breakthrough designation for computational pathology products.
Sunquest Information Systems Inc. provides diagnostic informatics solutions to laboratories worldwide. With our wide-ranging technical and cross-discipline expertise, and equally deep business acumen, no one is better equipped than Sunquest to transform your lab to meet today’s complex healthcare challenges and deliver next-level performance. Since 1979, Sunquest has helped laboratories and healthcare organizations enhance efficiency, improve patient care, and optimize financial results. Our capabilities include multi-site, multi-disciplinary support for complex anatomic, molecular and genetic testing, and support engagement with physicians and patients outside the hospitals at the point-of-care. Sunquest also provides solutions for public health organizations, in the form of disease surveillance and outbreak management, to promote public health wellness worldwide. Headquartered in Tucson, AZ with additional offices in Calabasas, CA, and India, Sunquest is a global leader in healthcare information technology.
Sunquest Information Systems has gained numerous industry acknowledgements, including several recognitions from Frost & Sullivan, #1 ranking by BlackBook Research, 50 Most Promising Healthcare Solution Providers – 2020 by CIO Review, and Breakthrough Technology by The Boston Globe.
Sunquest is owned by Roper Technologies, a diversified technology company, traded on the New York Stock Exchange under the symbol ROP.
Visiopharm® is a world leader in AI-driven precision pathology software.
Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in academic institutions, biopharmaceutical industry, and diagnostic centers. AI-based image analysis and tissue mining tools support research and drug development research worldwide, while CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, Visiopharm delivers tissue data mining tools, precision results, and workflows.
Visiopharm was founded in 2001 and is privately owned. The company operates internationally with over 900 licenses and countless users. The company headquarters are in Denmark’s Medicon Valley, with offices in Sweden, England, Germany, and the United States.